NCT00583622 2013-05-21Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsM.D. Anderson Cancer CenterPhase 2 Terminated13 enrolled 5 charts